Home pageCRL • NYSE
add
Charles River Laboratories International, Inc.
198,15Â $
After Hours:(0,00%)0,00
198,15Â $
Data e ora chiusura: 15 dic, 16:03:50 GMT-5 · USD · NYSE · Disclaimer
Chiusura precedente
193,03Â $
Intervallo giornaliero
195,10Â $ - 200,58Â $
Intervallo annuale
91,86Â $ - 200,58Â $
Cap di mercato
9,75Â Mld USD
Volume medio
1,02Â Mln
Rapporto P/E
-
Dividendo/Prezzo
-
Borsa valori principale
NYSE
Notizie
Dati finanziari
Conto economico
Entrate
Utile netto
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 1,00Â Mld | -0,49% |
Spese di gestione | 201,05Â Mln | -8,50% |
Utile netto | 54,42Â Mln | -21,87% |
Margine di profitto netto | 5,42 | -21,45% |
Utili per azione | 2,43 | -6,18% |
EBITDA | 165,25Â Mln | -30,05% |
Aliquota fiscale effettiva | 36,29% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 207,10Â Mln | -1,46% |
Totale attivo | 7,51Â Mld | -6,12% |
Totale passivo | 4,06Â Mld | -2,71% |
Patrimonio netto totale | 3,45 Mld | — |
Azioni in circolazione | 49,22 Mln | — |
Prezzo/valore contabile | 2,79 | — |
Redditività dell'attivo | 5,01% | — |
Rendimento sul capitale | 6,16% | — |
Flusso di cassa
Flusso di cassa netto
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | 54,42Â Mln | -21,87% |
Liquidità di esercizio | 213,83 Mln | -15,08% |
Contanti da investimenti | -33,70Â Mln | -58,02% |
Contanti da finanziamenti | -152,62Â Mln | 26,46% |
Flusso di cassa netto | 24,48Â Mln | -20,09% |
Flusso di cassa libero | 60,91Â Mln | -72,72% |
Informazioni
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Fondazione
1947
Sito web
Dipendenti
19.400